Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Jamie Samath Sells 108 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Jamie Samath sold 108 shares of the business’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. The trade was a 1.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Jamie Samath also recently made the following trade(s):

• On Friday, November 8th, Jamie Samath sold 22,903 shares of Intuitive Surgical stock. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00.
• On Monday, November 11th, Jamie Samath sold 269 shares of Intuitive Surgical stock. The stock was sold at an average price of $539.89, for a total value of $145,230.41.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $542.10 on Wednesday. Intuitive Surgical, Inc. has a fifty-two week low of $304.50 and a fifty-two week high of $552.00. The firm has a market cap of $193.09 billion, a price-to-earnings ratio of 87.15, a PEG ratio of 5.28 and a beta of 1.39. The firm has a 50 day moving average price of $506.81 and a 200-day moving average price of $466.29.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on ISRG shares. Royal Bank of Canada upped their price target on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. BTIG Research increased their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday. Raymond James raised their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday, October 14th. Robert W. Baird upped their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. Finally, The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $526.06.

Institutional Investors Weigh In On Intuitive Surgical

Several institutional investors have recently bought and sold shares of the stock. Mirador Capital Partners LP boosted its stake in shares of Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after purchasing an additional 50 shares during the period. Consolidated Planning Corp boosted its position in Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after buying an additional 1,198 shares during the period. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in Intuitive Surgical by 617.1% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock worth $39,622,000 after acquiring an additional 76,649 shares during the last quarter. Swiss National Bank increased its position in shares of Intuitive Surgical by 0.3% in the third quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock valued at $517,209,000 after acquiring an additional 3,400 shares during the period. Finally, ABLE Financial Group LLC bought a new position in shares of Intuitive Surgical during the third quarter valued at about $604,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.